Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers

Graft Function ◽

Hematopoietic Cell ◽

The Impact ◽

Poor Mobilizers ◽

Second autologous hematopoietic cell transplantation using long-term cryopreserved cells is associated with increased platelet transfusion support and hospital readmissions, but not delayed engraftment

Cytotherapy ◽

10.1016/s146532492100387x ◽

2021 ◽

Vol 23 (5) ◽

pp. S78

Author(s):

C. Neumann ◽

R. Knight ◽

G. Booth ◽

J. Dela Cruz ◽

R. Maziarz ◽

...

Keyword(s):

Cell Transplantation ◽

Platelet Transfusion ◽

Hospital Readmissions ◽

Hematopoietic Cell ◽

Cost–effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation

Leukemia ◽

10.1038/sj.leu.2402867 ◽

2003 ◽

Vol 17 (4) ◽

pp. 811-813 ◽

Cited By ~ 17

Author(s):

C Chabannon ◽

A-G Le Corroller ◽

F Viret ◽

C Eillen ◽

C Faucher ◽

...

Keyword(s):

Cost Effectiveness ◽

Cell Transplantation ◽

High Dose Chemotherapy ◽

Hematopoietic Cell ◽

High Dose ◽

Poor Mobilizers ◽

Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents

American Journal of Hematology ◽

10.1002/ajh.23753 ◽

2014 ◽

Vol 89 (8) ◽

pp. 825-830 ◽

Cited By ~ 43

Author(s):

Mohammed Al-Hamadani ◽

Shahrukh K. Hashmi ◽

Ronald S. Go

Keyword(s):

Multiple Myeloma ◽

Cell Transplantation ◽

Demographic Factors ◽

Initial Therapy ◽

Hematopoietic Cell ◽

Novel Agents ◽

The Impact ◽

Long-term outcomes of high-dose melphalan and carmustine followed by autologous hematopoietic cell transplantation for multiple myeloma.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.8026 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 8026-8026 ◽

Cited By ~ 2

Author(s):

Amarendra Kumar Neppalli ◽

Judith Shizuru ◽

Laura J. Johnston ◽

Lori S. Muffly ◽

Wen-Kai Weng ◽

...

Keyword(s):

Multiple Myeloma ◽

Cell Transplantation ◽

Hematopoietic Cell ◽

High Dose ◽

Long Term Outcomes ◽

High Dose Melphalan ◽

Long-term outcomes of innovator versus generic melphalan formulation in autologous hematopoietic cell transplantation for multiple myeloma

Hematology/Oncology and Stem Cell Therapy ◽

10.1016/j.hemonc.2020.06.002 ◽

2020 ◽

Author(s):

Deepesh P. Lad ◽

Pankaj Malhotra ◽

Amol N. Patil ◽

Ram V. Nampoothiri ◽

Kripa Shanker Kasudhan ◽

...

Keyword(s):

Multiple Myeloma ◽

Cell Transplantation ◽

Hematopoietic Cell ◽

Long Term Outcomes ◽

Faculty Opinions recommendation of Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1145192.604244 ◽

2009 ◽

Author(s):

Arnon Nagler

Keyword(s):

Multiple Myeloma ◽

Cell Transplantation ◽

Hematopoietic Cell ◽

Term Outcome ◽

Long Term Outcome ◽

Long Term Follow Up (LTFU) after Autologous Hematopoietic Cell Transplantation (AHCT) for Lymphoma and Multiple Myeloma: An Analysis of Patient Self-Reported Outcomes of Medical Conditions and Quality of Life (QOL)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2017.12.180 ◽

2018 ◽

Vol 24 (3) ◽

pp. S251-S252

Author(s):

George E. Georges ◽

Lynn Onstad ◽

Mary E. Flowers ◽

Paul A. Carpenter ◽

Jean C. Yi ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Cell Transplantation ◽

Hematopoietic Cell ◽

Long Term Follow Up ◽

A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up

Bone Marrow Transplantation ◽

10.1038/bmt.2012.51 ◽

2012 ◽

Vol 47 (11) ◽

pp. 1448-1454 ◽

Cited By ~ 4

Author(s):

K A Kasow ◽

C F Stewart ◽

R C Barfield ◽

N L Wright ◽

C Li ◽

...

Keyword(s):

High Risk ◽

Phase I ◽

Cell Transplantation ◽

Hematopoietic Cell ◽

Long Term Follow Up ◽

High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR

Bone Marrow Transplantation ◽

10.1038/bmt.2010.115 ◽

2010 ◽

Vol 46 (3) ◽

pp. 385-392 ◽

Cited By ~ 15

Author(s):

N S Majhail ◽

R Bajorunaite ◽

H M Lazarus ◽

Z Wang ◽

J P Klein ◽

...

Keyword(s):

Cell Transplantation ◽

High Probability ◽

Hematopoietic Cell ◽

Term Survival ◽

Long Term Survival ◽

Long-Term Survival and Late Relapse in 2-Year Survivors of Autologous Hematopoietic Cell Transplantation for Lymphoma

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2008.12.069 ◽

2009 ◽

Vol 15 (2) ◽

pp. 22-23

Author(s):

N.S. Majhail ◽

Z. Wang ◽

M.-J. Zhang ◽

H.M. Lazarus ◽

R. Bajorunaite ◽

...

Keyword(s):

Cell Transplantation ◽

Hematopoietic Cell ◽

Late Relapse ◽

Term Survival ◽

Long Term Survival ◽